Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Background<br/> Precision cancer medicine depends on defining distinct tumour subgroups using biomarkers that may occur at very modest frequencies. One such subgroup comprises patients with exceptionally mutated (ultramutated) cancers caused by mutations that impair DNA polymerase epsilon (POL...
Үндсэн зохиолчид: | Domingo, E, Freeman-Mills, L, Rayner, E, Glaire, M, Briggs, S, Koelzer, V, Frangou, E, Dutton, P, Kerr, R, Kerr, D, Tomlinson, I, Church, D, EPICOLON consortium |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
Lancet
2016
|
Ижил төстэй зүйлс
-
POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis
-н: Glaire, MA, зэрэг
Хэвлэсэн: (2016) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
-н: Van Gool, I, зэрэг
Хэвлэсэн: (2015) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
-н: Klenerman, P, зэрэг
Хэвлэсэн: (2015) -
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
-н: Van Gool, I, зэрэг
Хэвлэсэн: (2018) -
A panoply of errors: polymerase proofreading domain mutations in cancer
-н: Rayner, E, зэрэг
Хэвлэсэн: (2016)